Moderna announced Thursday that it had begun developing a possible vaccine that combines a COVID-19 dose and a seasonal influenza shot.
“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single-dose vaccine that combines a booster against COVID-19 and a booster against flu,” Moderna CEO Stéphane Bancel said in a news release.